Document:

Document

Adverum Biotechnologies, Inc. 
1035 O’Brien Drive,
Menlo Park, CA 94025
O: 650.272.6269

Exhibit 10.2
July 26, 2019

Angela Thedinga

Re: Employment Terms for Vice President, Program Management/Strategy

Dear Angela,

This letter agreement (the “Agreement”) memorializes the employment terms for your anticipated hire by Adverum Biotechnologies, Inc. (the “Company”) in the position of Vice President, Program Management/Strategy, reporting to Leone Patterson, Chief Executive Officer. These terms will become effective on or before August 1, 2019 or at a later date determined by mutual agreement (as applicable, the “Hire Date”).

Effective as of the Hire Date, your employment terms will be as follows:

1.Compensation and Benefits.

Your base salary will be $340,000.00 annually ($14,166.67 per pay period), subject to payroll deductions and all required withholdings, representing full-time employment with the Company.  Your salary will be paid in accordance with the Company’s standard payroll schedule.

In addition, for each calendar year starting with 2019 you will be eligible to earn an annual performance bonus with a target bonus amount equal to thirty percent (30%) of your base salary during the bonus year, subject to the applicable Company annual bonus plan. Your annual bonus for the 2019 calendar year may be prorated based on your Hire Date. Your annual bonus will be calculated based on attainment of individual goals (including corporate and personal objectives) to be determined by the Company’s management each year. Bonus payments will be in the form of cash, and will be granted entirely at the discretion of the Company’s CEO and Board of Directors. Any cash bonus payments will be less payroll deductions and all required withholdings. For each calendar year starting with 2019, in addition to a cash bonus, you may be eligible for an annual equity grant, provided that you are actively employed with the Company through and including the date of such annual equity grant. Your annual equity grant for the calendar year may be prorated based on your Hire Date.

A one-time signing bonus of $100,000 will be paid within the first thirty (30) days of your employment and will be subject to payroll deductions and all required withholdings. If you terminate your employment with the Company within eighteen (18) months of your hire date for any reason other than death, disability, or “Covered Termination” (as defined in the Change of Control and Severance Agreement) you will be responsible for repaying the signing bonus; or if the Company terminates your employment within eighteen (18) months of your hire date for Cause (as defined in the Change in Control and Severance Agreement) you will be responsible for repaying the signing bonus. You will be reimbursed for your travel, accommodations and transportation pursuant to the Adverum Travel and Entertainment policy for the first 3 months of your employment as you transition from Chicago to the bay area.
			
	

You will be eligible to participate in the Company’s general employee benefits in accordance with the terms, conditions and limitations of the benefit plans to the extent such plans have been established by the Company.

2.New Hire Equity Grant.

In addition to the compensation and benefits described above, the Company will grant you 100,000 stock options, representing the option to purchase shares of the Company’s common stock at a price equal to the closing price of the common stock on the Hire Date. The foregoing stock option award will be granted outside of the Company’s 2014 Equity Incentive Plan as an inducement grant and standard form of stock option agreement, and shall provide that 25% of the shares of common stock subject to the award of the option shall vest on the first anniversary of the vesting commencement date and 1/36th of the remainder of the award will vest monthly thereafter such that the entire award shall be vested and exercisable on the fourth (4th) anniversary of the vesting commencement date.

3.Confidentiality and Proprietary Information Obligations.

(a)Company Policies and Proprietary Information Agreement. You will be required to sign the Employee Proprietary Information and Inventions Assignment Agreement attached hereto as Exhibit A (the “Proprietary Information Agreement”).

(b)Adverse or Outside Business Activities. Throughout your employment with the Company, you may engage in civic, academic teaching and lectures, and not-for profit activities so long as such activities do not interfere with the performance of your duties hereunder or present a conflict of interest with the Company. You may not engage in other employment or undertake any other commercial business activities unless you obtain the prior written consent of the Company’s CEO. The Company may rescind its consent to your service as a director of all other corporations or participation in other business or public activities, if the Company, in its sole discretion, determines that such activities compromise or threaten to compromise the Company’s reputational or business interests or conflict with your duties to the Company. In addition, throughout the term of your employment with the Company, you agree not to, directly or indirectly, without the prior written consent of the Company, own, manage, operate, join, control, finance or participate in the ownership, management, operation, control or financing of, or be connected as an officer, director, executive, partner, employee, principal, agent, representative, consultant, licensor, licensee or otherwise with, any business or enterprise engaged in any business which is competitive with or which is reasonably anticipated to be competitive with the Company’s business; provided, however, that you may purchase or otherwise acquire up to (but not more than) one percent (1%) of any class of securities of any enterprise (but without participating in the activities of such enterprise) if such securities are listed on any national or regional securities exchange. You hereby represent and warrant that you have disclosed previously to the Board all other employment or other commercial business activities that you already undertake, or intend to undertake (to the extent currently known by you), during your period of employment with the Company.

4.No Conflicts.

By signing this Agreement you hereby represent to the Company that, except as previously disclosed to the Company: (a) your employment with the Company is not prohibited under any employment agreement or other contractual arrangement; and (b) you do not know of any conflicts which would restrict your employment with the Company. You hereby represent that you have disclosed to the Company any contract you have signed that may restrict your activities on behalf of the Company, and that you are presently in compliance with such contracts, if any.

5.At Will Employment.

Your employment relationship with the Company will be an “at-will” arrangement. This means that either you or the Company may terminate your employment at any time, with or without cause, and with or without advance notice. This “at-will” employment relationship cannot be changed except in a written agreement approved by the Company and signed by you and by a duly authorized officer of the Company.

6.Miscellaneous.

6.1.  Conditions of employment. As required by law, your employment is contingent upon satisfactory proof of your identity and legal authorization to work in the United States. Additionally, this offer is contingent upon your completion of the employment application, verification of your references, satisfactory completion of a pre-employment background check and execution of the Proprietary Information Agreement and the Acknowledgment of Business Ethics and Conduct Guide and Company Policies by or on your first day of employment.

6.2.  Entire agreement. This Agreement, together with your Proprietary Information Agreement (Exhibit A) and Change in Control and Severance Agreement, forms the complete and exclusive statement of your employment agreement with the Company. The employment terms in this Agreement supersede any other agreements or promises made to you by anyone, whether oral or written, concerning your employment terms.

6.3.  Succession and assignment. This Agreement is personal to you and shall not be assigned by you. Any purported assignment by you shall be null and void from the initial date of the purported assignment. The Company may assign this Agreement to any successor or assign (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company. This Agreement shall inure to the benefit of the Company and permitted successors and assigns.

6.4.  Enforceability. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible under applicable law.

6.5.  Governing law and jurisdiction. This Agreement shall be construed and enforced in accordance with the laws of the State of California without regard to conflicts of law principles any action or proceeding by either of the parties to enforce this Agreement shall be brought only in a state or federal court located in the state of California, county of San Mateo. The parties hereby irrevocably submit to the exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the maintenance of any such action or proceeding in such venue.

6.6.  Headings and captions. The captions of the sections of this Agreement are for convenience of reference only and in no way define, limit or affect the scope or substance of any section of this Agreement.

6.7.  No construction against drafter. Any ambiguity in this Agreement shall not be construed against either party as the drafter.

6.8.  Waiver. Any waiver of a breach of this Agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder.

6.9. Counterparts. This Agreement may be executed in counterparts, which shall be deemed to be part of one original, and facsimile signatures shall be equivalent to original signatures.

7.  Acknowledgement of Full Understanding. YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE FULLY READ, UNDERSTAND AND VOLUNTARILY ENTER INTO THIS AGREEMENT. YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF YOUR CHOICE BEFORE SIGNING THIS AGREEMENT.

Please sign and date this letter and return it to me by the close of business on July 29, 2019 in order to confirm your anticipated employment terms as set forth above.

We look forward to a productive and enjoyable work relationship with you.

Sincerely,
Adverum Biotechnologies Inc.:

												
	/s/ Leone Patterson			
	Leone Patterson			
	Chief Executive Officer			
				
	Understood and Accepted:			
				
				
	/s/ Angela Thedinga			
	Name: Angela Thedinga			
	Date: July 29, 2019Document

Exhibit 10.3
February 21, 2020
Angela Thedinga
Re: Promotion
Dear Angela,
Congratulations on a successful year at Adverum! This year has been eventful and challenging for all of us here at Adverum. We have met the huge challenge of scaling our business all while keeping our lab running efficiently and with integrity. We sincerely could not have done it without you.
As we review your performance in 2019 and look forward to continued growth and success in 2020 we are pleased to inform you that you have been selected for a promotion. Effective February 21, 2020, your new job title is Chief Technical Officer. This promotion comes with a salary increase resulting in a new base salary of $374,000. In addition to the increase in your salary, your target bonus percentage for 2020 has increased from 30% to 40%.
We are also excited to reward your performance with a bonus in the amount of $51,000.00.
In addition, Adverum’s Board of Directors has awarded you additional equity options as Incentive Stock Options (“ISO’s”) in recognition of your 2019 Performance Review and contributions to the success and growth of Adverum. Specifically, you have been awarded 150,000 ISO’s.
The ISO’s will vest and become exercisable as follows: subject to you continuing employment with the Company through each vesting date, 25% of the shares of common stock subject to the award of the Option shall vest on the first anniversary of the vesting commencement date (the date of the equity award) and 1/48th of the total shares granted shall vest and become exercisable monthly following such anniversary such that the entire award shall be vested and exercisable on the fourth anniversary of the vesting commencement date. The Option shall be subject to the other terms and conditions set forth in the Company’s 2017 Inducement Plan and the Company’s standard form of Nonstatutory Stock Option Agreement. You should consult with your own tax advisor concerning the risks associated with accepting the Option.
We look forward to another great year with you at Adverum.
Sincerely,
															
					
	/s/ Leone Patterson				
	Leone Patterson				
	Chief Executive Officer				
					
					

Adverum Biotechnologies, Inc.
800 Saginaw Drive Redwood City, CA, 94063

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}]]